Thrombolysed | Non-thrombolysed | p | |
---|---|---|---|
N = 37 | N = 41 | ||
Male, n (%) | 17 (46) | 10 (24) | 0.05 |
Age, mean (SD) | 91.7 (1.5) | 92 (1.8) | NS |
Vascular risk factors, n (%) | |||
Hypertension | 33 (89) | 35 (85) | NS |
Hypercholesterolemia | 15 (41) | 8 (20) | 0.04 |
Diabetes mellitus | 5 (14) | 4 (10) | NS |
Current smoking | 1 (3) | 0 | NS |
Medical history, n (%) | |||
Atrial fibrillation | 12 (32) | 9 (22) | NS |
Ischemic heart disease | 3 (8) | 3 (7) | NS |
Heart failure | 3 (8) | 5 (12) | NS |
Stroke or transient ischemic attack | 6 (16) | 10 (24) | NS |
Current treatment, n (%) | |||
Antiplatelets | 19 (51) | 20 (49) | NS |
Oral anticoagulants | 2 (5) | 6 (15) | NS |
Antihypertensive drugs | 28 (76) | 28 (68) | NS |
Statins | 12 (32) | 4 (10) | 0.01 |
Antidepressant drugs | 6 (16) | 3 (7) | NS |
Pre-stroke status | |||
IQCODE, mean (SD) | 3.2 (0.7) | 3.3 (0.5) | NS |
mRS > 1, n (%) | 14 (38) | 19 (46) | NS |
At home, n (%) | 32 (87) | 29 (71) | NS |
Nursing home, n (%) | 5 (14) | 12 (29) | NS |